Grupofarma Del Ecuador S.a.

What Grupofarma Del Ecuador S.a. does

GrupoFarma del Ecuador S.A. is a privately held pharmaceutical company headquartered in Quito, Ecuador, that develops, manufactures, and commercializes pharmaceutical and personal care products across seven therapeutic lines: cardiovascular, gastrointestinal, gynecology, iron supplements, urology, vitamins and supplements, and other specialty products. The company operates as the Ecuadorian subsidiary of Grupo Farma, a Venezuelan-origin Andean pharmaceutical corporation founded in 1941 with affiliated operations in Venezuela, Colombia, and Peru. GrupoFarma del Ecuador was legally constituted in 1995 and began commercial operations in 1997 with three brands, including Calcibon, and has since grown the portfolio to more than 70 products through organic development, brand acquisitions, and inbound licensing agreements with international partners such as Vifor Pharma (Switzerland) and Grossman (Mexico).

The company's product portfolio spans prescription and over-the-counter medications including antihypertensives (Aranda, Brasartan CTDN, Hidroten), gastrointestinal agents (Colypan, Hepalive Forte, MILPAX, Neolax, Oralyte, Vonau Flash), gynecological and iron-deficiency products (Calcibon line, Couplett, Ferinject, Venofer, Ferrum Hausmann), urology treatments (Prostum, Urocit-K), and vitamins/supplements (Bedoyecta, Cultiflor, Citramag, Farma D Mag, Kolgel). Manufacturing is supported by Grupo Farma's centralized laboratory infrastructure built since 1973, producing oral liquids, tablets, capsules, ointments, creams, and injectable solutions under formal pharmacovigilance and quality assurance frameworks; the parent FARMA S.A. was the first Venezuelan pharmaceutical laboratory to receive the COVENIN quality designation.

The business model is sales-led and B2B2C, targeting healthcare professionals via a medical representative sales force in Quito and Guayaquil, and reaching end patients through national and regional pharmacy chains in Ecuador under logistics partnerships (notably Logistecsa). Pricing is not publicly disclosed; products appear to be sold under standard prescription and OTC pharmacy distribution. Marketing combines direct physician engagement, a health-content blog (Novedades), and active organic social media presence on Instagram, Facebook, LinkedIn, and YouTube, supported by a pharmacovigilance reporting system for adverse events.

Name

Grupofarma Del Ecuador S.a.

Legal name

Grupofarma del Ecuador S.A.

Website

https://grupofarmadelecuador.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

GrupoFarma del Ecuador is a Quito-based pharmaceutical company that develops, manufactures, and markets 70+ products across seven therapeutic lines — cardiovascular, gastrointestinal, gynecology, iron, urology, and supplements — serving patients and healthcare professionals in Ecuador as part of Grupo Farma.

Ownership category

akta.pro rank

Product category

Pharmaceutical Products

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG)

akta.pro secondary industries

Probiotics & Digestive Health Supplements (CRADAGAF), Multivitamins & Daily Packs (CRADAGAC), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Pharmaceutical manufacturing
• Prescription medications
• Cardiovascular drugs
• Gastrointestinal drugs
• Dietary supplements

Headquarters

HQ city

Quito

HQ country

Ecuador

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Sale of pharmaceutical products across multiple therapeutic categories including cardiovascular, gastrointestinal, gynecological, iron supplements, urological, and vitamins/supplements. Products are sold through pharmacies and healthcare providers in Ecuador.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

GrupoFarma del Ecuador S.A. develops, manufactures, and commercializes a portfolio of more than 70 branded pharmaceutical and dietary supplement products across seven therapeutic lines (Cardiovascular, Gastrointestinal, Gynecology, Iron, Urology, Vitamins and Supplements, and Others) for the Ecuadorian market. Products are sold through pharmacy chains and retail outlets, with demand generation through a medical representative sales force engaging doctors and pharmacists, complemented by consumer-facing content marketing and pharmacovigilance support. Recognized brands include Calcibon, Bedoyecta, Hepalive, Aranda, Brasartan CTDN, Hidroten, Colypan, Ferinject, Ferrum Hausmann, MILPAX, and Vonau Flash.

Product overview

GrupoFarma del Ecuador is a pharmaceutical company with over 28 years of experience in Ecuador, operating as part of the Andean Grupo Farma corporation. The company develops, manufactures, and commercializes pharmaceutical products across seven therapeutic lines: Cardiovascular (including Aranda®, Brasartan® CTDN, Hidroten®), Gastrointestinal (including Colypan®, Fulrest®, Hepalive® Forte, Hepalive® Shot, MILPAX®, Neolax®, Oralyte®, Pridot®, Vonau Flash®), Gynecology (including Calcibon® D Soya, Calcibon® Natal Forte, Climasoy®, Couplett® Crema, Couplett® Plus Ovulos, Farma D mag®, Femen®), Iron supplements (including Ferinject®, Ferrum Fol®, Ferrum Hausman® Fol, Venofer®), Urology (Prostum®, Urocit®-K), Vitamins and Supplements (including Calcibon® D, Citramag®, Cultiflor, Farma Kidcal, FarmaDMag®, Kolgel®), and Other products (Bedoyecta®, Fullderma®, Tapazol®). The company maintains pharmacovigilance operations and serves healthcare professionals and patients in Ecuador.

Differentiator

Problem solved

Functional benefit

Brands

• Calcibon: Calcium and Vitamin D supplement line including Calcibon D, Calcibon D Soya, and Calcibon Natal Forte
• Bedoyecta
• Aranda
• Hepalive
• Brasartan CTDN
• Hidroten
• Colypan
• Ferinject
• Farma D Mag
• Vonau Flash
• Couplett
• Citramag
• Oralyte
• Neolax
• Ferrum Hausmann

Products and services

• Aranda Antihypertensive medication combining amlodipine and losartan potassium for the treatment of arterial hypertension in patients not adequately controlled with monotherapy. Targeted at patients with hypertension and prescribed by physicians.
• Brasartan CTDN Antihypertensive combination of valsartan and chlorthalidone for treatment of arterial hypertension and isolated systolic hypertension. Prescribed for hypertension management.
• Hidroten Diuretic containing chlorthalidone for treatment of arterial hypertension and isolated systolic hypertension. For patients requiring diuretic-based hypertension therapy.
• Colypan Trimebutine-based medication for treatment of Irritable Bowel Syndrome and associated discomfort. For patients with IBS and functional GI symptoms.
• Fulrest Diosmectite-based anti-diarrheal medication for treatment of acute and chronic diarrhea in children and adults. For pediatric and adult patients with diarrhea.
• Hepalive Forte Hepatoprotector supplement containing silymarin, ubiquinone (coenzyme Q), and B complex vitamins for fatty liver and liver disorders. For patients with hepatic conditions including fatty liver disease.
• Hepalive Shot Liquid dietary supplement containing silymarin, resveratrol, glutathione, coenzyme Q10, ascorbic acid, and B complex vitamins. For patients requiring hepatoprotective support.
• MILPAX / MILPAX NF Antacid and anti-reflux product with sodium alginate and sodium bicarbonate for relief of heartburn and gastroesophageal reflux. For patients with acid reflux and GERD symptoms.
• Neolax Laxative containing polyethylene glycol 3350 for treatment of chronic functional constipation. For adults and pediatric patients with chronic constipation.
• Oralyte Oral rehydration salts for restoration of electrolyte and fluid balance in mild to moderate dehydration from diarrhea. For patients requiring oral rehydration therapy.
• Pridot Prokinetic medication containing itopride hydrochloride for treatment of chronic gastritis symptoms and non-ulcer dyspepsia. For patients with functional gastric disorders.
• Vonau Flash (Ondansetron oral) Ondansetron-based antiemetic oral disintegrating tablets for prevention and treatment of nausea and vomiting in adults and pediatrics. For patients with chemotherapy-induced, post-operative, or gastroenteritis-related nausea.
• Calcibon D Calcium citrate and vitamin D dietary supplement for maintenance of normal bone health. For adults requiring calcium and vitamin D supplementation.
• Calcibon D Soya Dietary supplement containing calcium citrate, vitamin D3, magnesium oxide, and soy isoflavones for menopausal women. For peri/post-menopausal women requiring bone and hormonal support.
• Calcibon Natal Forte Nutritional supplement containing calcium citrate, vitamin D3, folic acid, and iron for women before, during, and after pregnancy. For pregnant and lactating women.
• Climasoy Dietary supplement containing active soy isoflavones for peri and post-menopausal women. For women experiencing menopausal symptoms.
• Couplett Crema Vaginal antibiotic and antifungal cream combining ketoconazole and clindamycin for treatment of mixed vaginal infections, bacterial vaginosis, and candidiasis in non-pregnant women. Prescribed by gynecologists.
• Couplett Plus Ovulos Vaginal ovules combining clotrimazole and clindamycin for treatment of bacterial, fungal, and mixed vaginal infections in pregnant women. Prescribed by gynecologists.
• Farma D mag Vitamin D3 (cholecalciferol) supplement in softgel capsules for treatment of vitamin D deficiency and insufficiency. For patients with diagnosed vitamin D deficiency.
• Femen

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Vifor PharmacoreOEM/ Whitelabel/ Licensing PartnerAcquired marketing license for iron products line from Swiss company Vifor Pharma, a world leader in the iron market. This partnership positioned GrupoFarma del Ecuador among the top laboratories in Ecuador.

Scale indicators2 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Laboratorios Bagó: Large Argentine-founded multinational pharmaceutical group with deep presence across Latin America, including Ecuador, marketing branded generics across cardiovascular, gastrointestinal, women's health, and CNS — directly overlapping GrupoFarma's therapeutic mix and regional distribution model.
• Eurofarma Ecuador: Brazilian-origin multinational generics and branded generics player expanding across Latin America including Ecuador; directly comparable in therapeutic coverage (cardio, gastro, women's health) and in targeting chronic-disease prescription demand.
• Bayer Ecuador: Multinational pharmaceutical and consumer health company with a strong Ecuadorian presence in cardiovascular, women's health, and supplements (e.g., Elevit, Supradyn); competes with GrupoFarma's Calcibon Natal Forte and iron supplement franchises at the premium end.
• Pfizer Ecuador: Global pharmaceutical multinational with a direct Ecuadorian sales force across cardiovascular, anti-infectives, and women's health; competes for the same physician detailing minutes and prescription share as GrupoFarma's cardiovascular line.

Regional players

• Farma de Colombia (Grupo Farma): Sibling Colombian subsidiary of Grupo Farma marketing overlapping cardiovascular, gastrointestinal, and supplement lines in Colombia; a relevant peer for understanding how GrupoFarma del Ecuador's brand portfolio performs in adjacent Andean markets.
• AC Farma (Peru): Peruvian pharmaceutical company within the same Grupo Farma corporate orbit, marketing similar cardiovascular, gastrointestinal, and supplement brands across Andean markets; a useful internal benchmark for GrupoFarma's regional expansion potential.

Direct peers

• Laboratorios Rocnarf: Ecuadorian pharmaceutical laboratory with broad portfolio across cardiovascular, gastrointestinal, and supplement lines; competes directly for shelf space and medical-rep detailing against GrupoFarma in the domestic market.
• Laboratorios Siegfried Ecuador: Ecuadorian pharmaceutical laboratory active in branded generics across multiple therapeutic categories, competing with GrupoFarma in pharmacy distribution and medical-rep coverage across Quito and Guayaquil.
• MK Ecuador (Laboratorios MK): One of Ecuador's leading domestic pharmaceutical laboratories offering branded generics across multiple therapeutic areas; competes with GrupoFarma's Aranda, Brasartan, and Calcibon franchises in retail pharmacy channels in Quito and Guayaquil.
• Genfar (Sanofi Ecuador): Ecuador-based branded generics manufacturer operating across cardiovascular, gastrointestinal, anti-infectives, and supplements; serves the same pharmacy channels and prescribers as GrupoFarma, and competes head-to-head for the same chronic-disease prescription volume.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@grupofarmadelecuador8067
• Facebookfacebook.com/GrupoFarmaDelEcuador?mibextid=2JQ9oc
• LinkedInlinkedin.com/company/grupofarma-del-ecuador
• Instagraminstagram.com/grupofarmadelecuador?igshid=MzRlODBiNWFlZA==

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupofarma Del Ecuador S.a.